June 06, 2023
Modi Goes to Washington: The Biden Administration is Playing the Long Game
Later this month Indian Prime Minister Narendra Modi will visit Washington on a much-coveted state visit that is shaping up to be a historic occasion. Washington’s warm welcome of Modi takes place, despite the two countries' major differences over Russia’s invasion of Ukraine, and in the context of rising tensions between Washington and Beijing and a slew of wins for the Biden administration in implementing its Indo-Pacific strategy.
All signs point to a historic visit this month by Modi that will also further validate the success of the Administration’s Indo-Pacific strategy.
Outside observers may question why the Biden Administration is extending the courtesy of a state-level visit to Modi, whose government has given succor to Moscow by abstaining from several United Nations resolutions condemning Russia, drastically increasing imports of Russian crude oil, and participating in Russian military exercises.
Read the full article from NatStrat.
More from CNAS
-
Podcast
Defense / Indo-Pacific Security
Hellscape Taiwan: Drones, Deterrence, and the Future of Asymmetric DefenseStacie Pettyjohn joined the Irregular Warfare Podcast to examine how Taiwan could deter—or potentially defeat—a Chinese invasion by transforming the Taiwan Strait into an “unm...
By Stacie Pettyjohn
-
Video
Indo-Pacific Security / Energy, Economics & Security
Analysts Break Down Trump-Xi Meeting and Calls for Stability and CooperationFor perspective on President Trump's trip and the broader U.S.-China relationship, Geoff Bennett spoke with Myron Brilliant and Liza Tobin. Brilliant is at the DGA Group and i...
By Liza Tobin
-
Video
Indo-Pacific Security / Energy, Economics & Security
Rajdeep Sardesai Asks Big Question on US-ChinaThe debate on the Big Question, with Daniel Silverberg, adjunct senior fellow at the Center for a New American Security, explores whether Beijing holds the key to resolving th...
By Daniel Silverberg
-
China’s Pharmaceutical Weapon
Commentary
Until SAPIR is extended to biologically derived drugs, until the FDA clears the bovine pathway, and until at least one American-owned heparin manufacturer operates on US soil,...
By Jennifer Hendrixson White
